Refine
Document Type
- Doctoral Thesis (17)
Has Fulltext
- yes (17)
Is part of the Bibliography
- no (17)
Keywords
- Biokatalyse (5)
- Protein Engineering (4)
- Biocatalysis (3)
- Proteindesign (3)
- Enzym (2)
- Protein engineering (2)
- 7 beta Hydroxylierung (1)
- Abbau (1)
- Acyltransferase (1)
- Acyltransferasen (1)
Institute
Haloalkanes are serious environmental pollutants commonly employed as pesticides, herbicides, and chemical warfare agents. Although haloalkane production is performed mostly in the chemical industry, it also occurs naturally, mostly enzymatically (halide methyltransferases and haloperoxidases). Elimination of toxic haloalkanes is very important and using haloalkane dehalogenases is a promising and environmentally friendly way to achieve this.[53] Therefore, assays are needed for detecting dehalogenase activity either to find new enzymes or to generate laboratory-evolved variants. In this thesis, a new assay for dehalogenase activity was developed based on halide detection. In this assay halides, as dehalogenase products, are oxidized under mild conditions using the vanadium-dependent chloroperoxidase from Curvularia inaequalis, forming hypohalous acids that are detected using aminophenyl fluorescein.[53] This new halide oxidation assay is much more sensitive than previously known assays, with detection limits of 20 nM for bromide and 1 μM for chloride and iodide. Validation of the assay was done by comparison to a well-established GC-MS method in terms of determining the specific activities of two dehalogenases towards five common substrates (Figure 5).
The HOX assay was modified for iodide-specific detection by using two other dyes, o-phenylenediamine (OPD) and 3,3′,5,5′-tetramethylbenzidine (TBM), instead of APF. Also, selective bromide detection in the presence of the common contaminant chloride was achieved by using a bromoperoxidase. Since the assay relies on halide detection, it is possible to use it for other halide-producing enzymes (Section 8.1). For example, the TMB-modified version was used for screening of halide methyltransferase libraries towards various alkyl iodides.[166] Furthermore, the HOX assay was used to identify promiscuous dehalogenase activity of the epoxide hydrolase CorEH from Corynebacterium sp. C12.[105]
Moreover, studies showed that the HOX assay could be used with in-vitro synthesized protein. Selected dehalogenases, DhlA, DhaA, and DmmA, were synthesized in vitro and used in the assay; the product formation was also validated using GC-MS. In conclusion, the HOX assay can be used with purified protein, whole cells, or in vitro synthesized proteins.
The HOX assay application in microfluidic droplets was investigated since an ultra-high-throughput assay for haloalkane dehalogenases is needed. This investigation showed no leakage of reaction components and products in the short term (~24 h), based on tests done on water-in-oil droplets generated by microfluidic chips. Even though 20 μM droplets were not working, 70 μM droplets were successful for assay implementation. Since the Damborsky group in Brno (CZ) and the deMello group in Zürich (CH), have large dehalogenase libraries and more experience in microfluidics, respectively, we collaborated with these groups to finalize implementation of the assay in an ultrahigh-throughput format. Since the studies are ongoing, final results could not yet be shown in this thesis. However, it can be noted that the issue with 20 μm droplets has been sorted out since our collaborators in Brno noticed that the low fluorescence of the droplets is actually caused by excessive accumulation of fluorescein, which is self-quenching, resulting in low fluorescence once the concentration exceeds 1 μM. By lowering the APF concentration they could optimize the maximum amount of fluorescein formed, and a mutant library has now been successfully screened by our collaborators at the ETH. The last topic of the thesis was an investigation of converting an epoxide hydrolase into a haloalkane dehalogenase. These studies focused on increasing the minor dehalogenase activity of two previously identified epoxide hydrolase (Cif) variants. These Cif variants hardly led to soluble proteins, the PROSS algorithm was used to increase soluble expression. New variants of Cif were generated using a 3DM analysis and the PROSS[164] design. The activities of these variants were determined with the newly developed HOX assay in a whole-cell format. Cif23 E153N-H269D and the PROSS D7 E153N-H269D variant, were found being active against 1,2-dibromoethane. Since the determination of enzyme concentration was hard to measure due to the expression/purification problem, specific activities could not be determined. To solve this problem, a HiBiT-tag was added to the selected variants for determining soluble expression. However, the planned studies could not be completed because of a lack of time and will form the basis for a future study.
This thesis focuses on the establishment of biocatalytic cascade reactions for the production and detection of industrially relevant flavor and fragrance compounds for food and cosmetic products. To meet the consumer’s demand for those products to be natural, environmentally friendly biocatalytic manufacturing processes that operate GMO-free must be established. Thus, this thesis presents such pathways for the production of an industrially relevant long-chain hydroxy fatty acid and the important flavor and aroma compound raspberry ketone. Furthermore, a biosensor for aldehyde detection was implemented to facilitate screening for suitable biocatalysts that produce industrially relevant aldehydes that are widely applied in the flavor and fragrance industry.
In contrast to its terrestrial counterpart, the metabolic degradation of marine polysaccharides is underexplored. This work aimed to functionally characterize ulvan- and xylan-degrading enzymes from marine Bacteroidetes in order to clarify the metabolic degradation pathway. For the provision of a broad polysaccharide substrate spectrum, ulvan from several different algal sources was extracted to be used in further characterization experiments. The structural differences of these ulvans could be demonstrated by enzymatic degradation with ulvan-active enzymes. In order to clarify the synergistic catalytic effects of polysaccharide sulfatases with GHs in the degradation process of ulvan, several putative sulfatases from F. agariphila were produced recombinantly in E. coli. For that, a coexpression with an FGE encoding gene was required. It could be demonstrated that several glycoside hydrolases are inhibited, if their
substrate is sulfated at the cleavage position and that a previous desulfation using one of the sulfatases enabled the further degradation. Some of the sulfatases showed an endolytic or exolytic cleavage behavior like reported for several GHs. With the combined catalytic activities, it was possible to successfully elucidate the complex ulvan degradation mechanism for the first time, which enables the use of ulvan as a biotechnological source for the production of fine chemicals and pharmaceuticals. This degradation mechanism was shown to be complemented by an alternative pathway that helps with the degradation of uronic acid-containing oligosaccharides. Here, the synergistic effects of a multimodular enzyme containing a sulfatase and rhamnosidase domain were demonstrated. Furthermore, the first dehydratase participating in the degradation of oligosaccharides was revealed. The functional characterization of putative xylan-targeting PULs from two Flavobacteriia revealed the existence of marine endolytic and exolytic xylanases. The enzymes of these PULs were produced recombinantly in E. coli and were used in biocatalysis reactions on xylan from beechwood, xylan from P. palmata or commercial xylooligosaccharide standards. Further side chain-active GHs were found to exclusively be active on either standards or xylan. The great variation of genetic equipment was demonstrated by comparing the enzyme activities of these PUL structures assuming different ecological adaptations of these organisms especially, because these PULs do not code for any putative sulfatases, which is uncommon for PULs targeting xylan. A different degradation behavior of the investigated enzymes suggested a preferred conversion of β-1,4-linked xylan, potentially present in some microalgae. The acquired insight of the metabolic ulvan and xylan utilization greatly expands the scientific knowledge about the ecologic interplays in marine environments concerning the polysaccharide utilization. It indicates the necessity of backup mechanisms for metabolic processes in order to get access to complex marine carbon sources in nature. Several small degradation cascades complement each other to break down substrate compounds to monomeric level for the use of structurally diverse polysaccharides. This expands the insights into the metabolic processes in the degradation of marine polysaccharides, which are an important part of the understanding of the ecological interactions in aquatic habitats and the ocean’s carbon cycle.
The characterization of ulvan- and xylan-active enzymes and the clarification of their substrate scopes allow to use these enzymes in future production of carbohydrate-derived chemical products for many industrial applications, making it possible to use algal waste for recycling to high value materials with even beneficial effect for the environment.
Promiscuous acyltransferases enable transesterification reactions in bulk water by preferentially catalyzing acyl transfer over hydrolysis. Until recently, only a small number of promiscuous acyltransferases have been described in the literature, exhibiting several limitations in terms of acyltransferase efficiency and applicability. This work focuses on the discovery of novel promiscuous acyltransferases and the engineering of promiscuous acyltransferases via rational design. Several promiscuous acyltransferases in the bacterial hormone-sensitive lipase family and family VIII carboxylesterases have been identified, demonstrating that promiscuous acyltransferase activity is not a rare phenomenon. Moreover, the efficiency and applicability of the enzymes could be improved via protein engineering in terms of acyltransferase activity, enantioselectivity, and substrate scope.
The aims of this thesis were the identification and development of whole-cell biocatalysts for the regio- and stereoselective hydroxylation of steroids, including hormones and bile acids by P450 monooxygenases. Steroids and their derivatives are applied as therapeutic agents. The chemical synthesis of such compounds depends on multi-step procedures, in a stereo- and regiospecific manner involving the protection and deprotection of functional groups and toxic reagents and intermediates. In this thesis, different P450 monooxygenases were investigated as ‘bio-based’ alternatives to chemical catalysts for the late-stage functionalization of steroids and bile acids and engineered by directed evolution procedures towards desired transformation activities. In Article I, the 16α-hydroxylation activity of the bovine CYP17A1 was enhanced by protein engineering to improve the transformation of progesterone into 16α-hydroxyprogesterone in Saccharomyces cerevisiae. Article II follows the same line of research and targets the selective synthesis of bile acid derivatives in Escherichia coli (E. coli) whole-cells. The P450 monooxygenase CYP107D1 (OleP) from Streptomyces antibioticus (S. antibioticus) was identified, which selectively hydroxylates bile acids like lithocholic acid (LCA) and deoxycholic acid (DCA) at the 6β-position, yielding murideoxycholic acid (MDCA), a gallstone solubilizing agent, and 3α-,6β-,12α-trihydroxy-5β-cholan-24-oic acid, respectively. The utilization of OleP as catalyst resulted in shorter synthesis routes for both compounds and additional in a higher yield for MDCA. Building on the results of Article II and the protein engineering approach from Article I, Article III deals with the switch of regioselectivity of the identified CYP107D1 from 6β- to 7β-hydroxylation to form the therapeutic agent ursodeoxycholic acid (UDCA) from LCA by direct hydroxylation. Following a rational protein engineering strategy, a variant with nearly perfect selectivity for UDCA formation was found. Until today, UDCA is either isolated from bile of catheterised farmed bears or produced semisynthetically through low-yielding multistep reactions starting from cholic acid (CA). Article III presents the first reported enzyme for the direct 7β-hydroxylation of LCA to UDCA.
Als hochmaligner Tumor stellt das Neuroblastom ausgehend vom sympathischen Nervensystem den häufigsten soliden, extrakraniellen Tumor des Kindesalters dar. Aufgrund seiner heterogenen Charakteristik und teils höchst aggressiven Wachstums bedarf es besonders im Hinblick auf die hohe Rezidivrate von Hochrisikopatienten neuer innovativer Therapien, die einen langanhaltenden Anti-Tumoreffekt induzieren. Durch zunehmende Erkenntnisse auf dem Gebiet der Tumorimmunologie sind dabei besonders immuntherapeutische Behandlungsstrategien immer weiter in den Vordergrund gerückt. Diese führen zur spezifischen Aktivierung des körpereigenen Immunsystems verbunden mit der Erkennung und Eliminierung der Tumorzellen. In der Praxis ist eine wirksame Anwendung der aktiven Immuntherapie jedoch mit einigen Herausforderungen verbunden. Dazu gehören die Identifikation von geeigneten Tumorantigenen, die optimale Aufnahme, Prozessierung und Präsentation der Antigene durch Immunzellen sowie die Überwindung der Immuntoleranz zur Induktion zytotoxischer und Gedächtnis-T-Zellen. Auch die natürlichen Regulationsmechanismen sollten nicht außer Acht gelassen werden, da diese einerseits die anti-tumoralen Effekte einer resultierenden Immunantwort eindämmen können, jedoch andererseits gesundes Gewebe vor einer Autoimmunreaktion schützen. Ziel dieser Arbeit war es daher die bereits bekannte präklinische Wirksamkeit einer Tyrosinhydroxylase (TH)-gerichteten Immuntherapie gegen das Neuroblastom durch eine zusätzliche Immunstimulation mit dem Zytokin IL-15 und einer Immuncheckpoint-Blockade zu verbessern. Dafür wurde ein bicistronisches DNA-Vakzin generiert, welches sowohl für die cDNA der TH als auch die von IL-15 kodiert. Um dabei die Herstellung und MHC-I-vermittelte Präsentation antigener TH-Peptide, effektiv zu gestalten und die Immunigenität des Vakzins zu erhöhen, erfolgte die upstream-Kopplung einer modifizierten Ubiquitin-Sequenz an die der xenogenen TH. Die Integration der IL-15-Sequenz in das DNA-Vakzin ermöglicht eine auf die Mikroumgebung der Antigenpräsentation beschränkte lokale Applikation und kann so die Aktivierung zytotoxischer T-Zellen unterstützen ohne systemische Zytokin-bedingte Nebenwirkungen zu verursachen. Nach der Generierung des Vakzins erfolgte die In-vitro-Charakterisierung durch Transfektion von CHO-Zellen mit dem DNA-Vakzin, wobei die Plasmid-vermittelte Synthese der ubiquitinierten TH und Freisetzung von bioaktivem IL-15 bestätigt wurden. Die Evaluierung der anti-tumoralen Eigenschaften in vivo erfolgte in einem syngenen Mausmodell, wobei attenuierte S. typhimurium SL7207 als orales Applikationsvehikel für das DNA-Vakzin dienten, die durch die Stimulierung des mukosalen Immunsystems dem DNA-Vakzin eine gesteigerte Immunogenität verleihen. Im Rahmen dieser Arbeit konnte der S. typhimurium-vermittelte Genransfer sowie die effektive Expression der im Vakzin enthaltenen Gene in den APC der Peyer Plaques nachgewiesen werden. Weiterhin konnten die durch zytotoxische T-Zellen vermittelte anti-tumoralen Effekte einer TH-basierten Immuntherapie, repräsentiert durch ein reduziertes Primärtumorwachstum sowie verminderter Metastasierung, durch die Ko-Expression von IL-15 in einem syngenen Mausmodell gesteigert werden. Interessanterweise führte die Immuncheckpoint-Blockade durch eine anti-PD-1-AK-Therapie sowohl mit als auch ohne Kombination mit dem DNA-Vakzin zu einem signifikanten Anstieg der anti-tumoralen Effekte. Dieses Ergebnis unterstreicht die nachteilige Rolle immunregulatorischer Mechanismen bei der Ausbildung einer zellulären Immunantwort durch eine Immuntherapie, was ergänzend durch den Nachweis immunsuppressiver Zytokine in der Tumormikroumgebung bestätigt wurde. Bei der Anwendung von Behandlungsstrategien zur aktiven Immunisierung ist daher die Blockierung der natürlichen Regulationsmechanismen sowie der tumor-induzierten Immunsuppression von enormer Bedeutung.
Zusammenfassend war das in dieser Arbeit generierte xenogene DNA-Vakzin in der Lage durch die Ko-Expression von IL-15 die NB-spezifischen Effekte der TH-gerichteten Immuntherapie zu steigern. Des Weiteren konnten mittels einer anti-PD-1-gerichteten Immuncheckpoint-Blockade immunregulatorische Prozesse unterbunden und dadurch die CTL-vermittelten anti-tumoralen Effekte der Target-gerichteten DNA-Vakzinierung verstärkt werden. Gerade bei schwach immunogenen Tumoren wie dem Neuroblastom sind Kombinationstherapien notwendig, welche eine TAA-gerichtet Immunantwort zur Induktion eines Immunologischen Gedächtnisses in Gang bringen und gleichzeitg die Regulationsmechanismen unterbinden, um so eine effektive Tumorbekämpfung zu ermöglichen. Diese vielversprechende Vakzinierungsstrategie könnte somit neuer immunologischer Ansatz für eine adjuvante Erhaltungstherapie für eine minimale Resterkrankung bei refraktären Neuroblastompatienten darstellen.
In the 1940s cytochrome P450 monooxygenases have been discovered and have been the focus of many studies ever since. Although they catalyze very interesting reactions that might find applications in the production of fine chemicals or pharmaceuticals, their low activity and stability often reduces their economic value. Both properties, the activity and the stability, are influenced by the uncoupling of the catalytic cycle.
In this PhD thesis, an assay for the screening of activity and uncoupling of cytochrome P450 enzymes was successfully developed. After finding optimal conditions for the assay, concerning pH and enzyme concentration, the uncoupling of cytochrome P450 BM3 and five mutants (F87Y, R47L, Y51F, A82L and T268A) was investigated. With the results obtained, a comparison of data from literature was possible and revealed similarities. Additionally, through negative controls, the reliability of the assay could be further demonstrated. Although other methods have been described for the detection of hydrogen peroxide formation, the combination of NADPH consumption measurement and hydrogen peroxide formation in parallel was new and represents a very good basis for a pre-screening of large mutant libraries, followed by closer investigation of selected variants.
For the investigation of the activity of the CYP11A1 system, consisting of CYP11A1 and Adx and AdR as redox partner system, the expression and purification for all three proteins was investigated first. For the protein CYP11A1 and Adx, good expression levels were achieved, whereas for AdR the protein concentration obtained was very low. The purification of all three proteins was partially accomplished but left room for improvement. Therefore, in the Master thesis of Christopher Grimm, the pH and temperature stability of all three proteins was further investigated in order to improve conditions used for ion exchange chromatography and to investigate possible conditions for in vitro biocatalysis. As unfortunately even with further investigation of the expression of AdR, no improvement was achieved, a whole-cell system was further investigated. Here, the product formation could be increased 8-fold in comparison to the published data, from 0.27% conversion to 2.2% conversion over 24 h by using a different detergent for substrate solubilization, which might have led to a better substrate supply to the enzyme.
Due to the low activity and stability, a different P450 system, the CYP17A1 enzyme, was subsequently investigated, first by in vitro biocatalysis with the human CYP17A1 expressed in E. coli. Therefore, a suitable redox partner system needed to be found for efficient electron supply of the enzyme. In in vitro biocatalysis, in combination with the Pdx/PdR system of P. putida the CYP17A1 enzyme showed the highest conversion with 91% after 24 h. To investigate the activity of the enzyme further, all active site residues in 4 Å proximity to the bound substrate were exchanged with alanine. After expression of the variants, almost no correctly folded protein was obtained for the variants. Also, after investigating different buffers to possibly enhance the stability, no improvements were achieved. Therefore, a whole-cell approach with the bovine enzyme was chosen in order to investigate the activity of the alanine variants. Here the importance of positions N202, R239, G297, E305, and T306A, described in literature to be important for catalytic activity, was confirmed. Most importantly, three positions that alter the regioselectivity of the enzyme were identified. The reaction of the V483A mutant was therefore also further investigated by preparative biocatalysis. Afterwards the new product was separated by preparative HPLC and identified as 16α- hydroxyprogesterone as confirmed by NMR spectroscopy analysis.
In the last part of the thesis, another screening approach for possible high-throughput screening was investigated. In contrast to the other screening approach, here the investigation of the substrate conversion and the hydrogen peroxide formation were optimized for application in droplets. After finding that DCFH-DA was not sensitive enough towards hydrogen peroxide, the AmplifluTM Red probe was used. As both fluorescent products were found to stay in the aqueous phase above pH 7.4, the conditions investigated for the AmplifluTM Red assay were applied and only NADPH to substrate ratio was investigated by using an uncoupling variant, an active variant from literature and the cytochrome P450 BM3 wild-type enzyme. After finding a good ratio, the five variants used for the investigation of the AmplifluTM Red assay were investigated in the same concentration later on found in the droplets (1 cell per 4 pL), and one variant showed improved product formation compared to wild-type. This finding clearly shows the applicability of the assay for high-throughput screening in droplets.
Unter promiskuitiver Acyltransferase-Aktivität versteht man die Eigenschaft bestimmter Hydrolasen, in wässriger Lösung bevorzugt Acyltransfer statt Hydrolyse zu katalysieren. Bis vor Kurzem waren nur wenige promiskuitive Acyltransferasen literaturbekannt. Dies führte zu der allgemeinen Annahme, dass diese Aktivität ein seltenes Phänomen in Hydrolasen ist. Diese Arbeit zeigt jedoch, dass promiskuitive Acyltransferase-Aktivität in der Familie der bakteriellen hormonsensitiven Lipasen und Carboxylesterasen der Familie VIII weit verbreitet ist. Detaillierte Struktur-Funktions-Analysen ermöglichen die sequenzbasierte Vorhersage und Optimierung der Acyltransferase-Aktivität in beiden Enzymfamilien. Insbesondere die Carboxylesterasen der Familie VIII überschreiten die Grenzen des bisher für möglich Gehaltenen, indem sie gute Enantioselektivität bei der kinetischen Racematspaltung sekundärer Alkohole zeigen und darüber hinaus die irreversible Bildung von Amiden und Carbamaten in Wasser katalysieren können. Die biokatalytische Acylierung von Zuckern in Wasser galt lange Zeit als unerreichtes Ziel der Biokatalyse. In dieser Arbeit wurde jedoch gezeigt, dass natürlich vorkommende und modifizierte Carboxylesterasen der Familie VIII die regioselektive Acetylierung von Glucose, Maltose und Maltotriose in Wasser mit hoher Effizienz katalysieren können.
In their idealized forms, enzymes can facilitate complex reactions with extreme specificity and selectivity. Additionally, in this imaginative form, they only require mild reaction conditions, resulting in low energy consumption, and they are biodegradable, efficient, reusable, and sustainable. Unfortunately, this idealized form often deviates significantly from reality, where enzymes are more likely to be associated with marginal stability and low reaction rates, leaving them less than desirable for many industrial applications. As such, if we could master the process of engineering the configuration of a protein towards a given task, the implications could be staggering.
This thesis aims to contribute to the process of protein engineering, mainly how computational tools can be used to make the protein engineering process more efficient and accessible.
Article I explores the current state of the art in machine learning-guided directed evolution and serves as a foundation for Article II, which is a concrete application of these techniques to an engineering campaign. Despite successfully improving overall activity and selectivity, we also observe limitations and constraints within the methodology. Article III then delves into these drawbacks and attempts to lay the foundation for a more generalizable and, more importantly, efficient engineering workflow, balancing the strengths and weaknesses of computational techniques with advances in gene synthesis. We then validated this novel pipeline in Article IV, where we show the potential of this methodology. Article V describes a more standard protein engineering campaign on squalene-hopene cyclases for potentially interesting products in the flavor and fragrance industry. Lastly, Article VI outlines a PyMol plugin for molecular docking.
This thesis deals with the characterisation and engineering of new thermophilic PET hydrolases as potential candidates for an eco-friendly biocatalytic recycling approach for the upcycling or downcycling of polyethylene terephthalate (PET) on industrial scale. Furthermore, high-throughput screening methods are described that detect the products of PET hydrolysis. The high demand of PET in the packaging and textile industries with a global production of 82 million metric tons per year has significantly contributed to the global solid waste stream and environmental plastic pollution after its end-of-life. Although PET hydrolases have been identified in various microorganisms, only a handful of benchmark enzymes have been engineered for industrial applications. Therefore, the identification of new PET hydrolases from metagenomes or via protein engineering approaches, especially thermophilic PET hydrolases with optimal operating temperatures (i.e., increased thermostability and activity) near the glass transition temperature of the polymer PET, is a crucial step towards a bio-based circular plastic economy. Article I demonstrates that metagenome-derived thermophilic PET hydrolases can be significantly improved using different engineering approaches to achieve a similar activity level as the well-established leaf-branch-compost cutinase (LCC) F243I/D238C/S283C/Y127G variant (LCC ICCG). In Article II, thermostable variants of a mesophilic enzyme (PETase from Ideonella sakaiensis) were identified from a mutant library and characterised against PET substrates in various forms. Articles III and IV describe the application of high-throughput methods for the identification of novel PET hydrolases by directly assaying terephthalic acid (TPA), one of the monomeric building blocks of PET. Furthermore, Article IV describes the possibility of a one-pot conversion of the TPA-based aldehydes produced to their diamines as example for an open-loop upcycling method.